Latest Breaking News On - Immunotherapy center at massachusetts - Page 1 : comparemela.com

Harvard Docs Train Ukrainian Counterparts 2 Years Into War

Boston program aimed to mentor specialists whose medical education was forged in the remnants of the old Soviet system.

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript

Operator: Good evening, and welcome to the Dyadic International s Third Quarter 2023 Financial Results Conference Call. Currently all participants are in a listen-only mode.

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript November 8, 2023 Dyadic International, Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. Operator: Good evening, and welcome to the Dyadic International’s Third Quarter 2023 Financial Results Conference Call. Currently all participants are in a listen-only mode. Following management’s prepared […]

Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts General Hospital as Part of VIC's $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases -October 05, 2023 at 08:32 am EDT

JUPITER, Fla., Oct. 05, 2023 Dyadic International, Inc. , a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein.